Pietro Merli

40PUBLICATIONS
209CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Aug 31, 2026
Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome.

|Aug 25, 2026
Interindividual HLA evolutionary divergence in mismatched unrelated donor allo-HCT for malignant hematological disorders.

|May 15, 2026
Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM.

|May 11, 2026
A specific stem cell program and CD112 immunological axis dysfunctions underpinning monosomy 7-associated myeloid neoplasms.

|Mar 03, 2026
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia.

Marco Becilli, Pietro Merli, Mattia Algeri

|Feb 05, 2026
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases.

Marco Becilli, Markus Metzler, Claudia Bracaglia

Pageof 7

Frequent Collaborators

21 joint publications

Franco Locatelli

8 joint publications

Valentina Bertaina

7 joint publications

Elizabeth O Hexner

7 joint publications

Muna Qayed